Is Candida really a threat in the ICU?

Area of Science:

• Infectious Diseases
• Critical Care Medicine
• Medical Mycology

Background:

• Candida species represent a significant cause of hospital-acquired infections, particularly in intensive care units (ICUs).
• Accurate diagnosis of invasive candidiasis is challenging, especially when relying on non-blood cultures.
• The clinical and epidemiological significance of Candida colonization and invasive infections in critically ill patients warrants careful consideration.

Purpose of the Study:

• To review the epidemiological and clinical relevance of Candida in the ICU.
• To appraise the prevalence of Candida, the significance of non-blood culture positivity and multisite colonization, and the impact of invasive candidiasis on mortality.

Main Methods:

• Literature review focusing on epidemiological data and clinical outcomes related to Candida in ICUs.
• Analysis of studies addressing the diagnostic challenges of invasive candidiasis using non-blood cultures.
• Evaluation of the role of Candida colonization, including multisite colonization, in predicting invasive disease.

Main Results:

• Invasive candidiasis diagnosis is difficult, hindering accurate prevalence assessment and potentially leading to delayed antifungal therapy.
• Candida spp. account for a small percentage of nosocomial bloodstream infections (4-9%).
• Multisite colonization often precedes invasive candidiasis and is a key factor in initiating preemptive therapy, though its predictive value is limited without clear risk factors.

Conclusions:

• Delayed antifungal therapy in invasive candidiasis significantly increases attributable mortality.
• Distinguishing colonization from invasive disease is problematic, especially with non-blood culture findings.
• Multisite Candida colonization is an important indicator for preemptive therapy in ICU patients, but its predictive accuracy varies.